Another Setback For Glitazones: Germany Withdraws Reimbursement For The Diabetes Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal joint committee decision means GSK's Avandia and Takeda's Actos no longer will be reimbursed in Germany other than in exceptional cases.